BeOne Medicines Ltd. (HKG:6160)
Hong Kong · Delayed Price · Currency is HKD 184.20
+7.00 (3.95%)
Aug 29, 2025, 4:08 PM HKT
BeOne Medicines Market Cap
BeOne Medicines has a market cap or net worth of 262.49 billion as of August 29, 2025. Its market cap has increased by 70.03% in one year.
Market Cap
262.49B
Enterprise Value
249.00B
Revenue
35.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
184.20
Market Cap Chart
Since February 3, 2016, BeOne Medicines's market cap has increased from 6.70B to 262.49B, an increase of 3,819.66%. That is a compound annual growth rate of 46.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 262.49B | 71.83% |
| Dec 31, 2024 | 152.77B | 4.09% |
| Dec 29, 2023 | 146.76B | -17.60% |
| Dec 30, 2022 | 178.11B | -17.96% |
| Dec 31, 2021 | 217.12B | 19.19% |
| Dec 31, 2020 | 182.15B | 130.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 3, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hansoh Pharmaceutical Group Company | 218.06B |
| JD Health International | 199.69B |
| Innovent Biologics | 165.88B |
| Akeso | 139.76B |
| Sino Biopharmaceutical | 138.43B |
| WuXi Biologics | 135.14B |
| CSPC Pharmaceutical Group | 115.13B |
| Sichuan Kelun-Biotech Biopharmaceutical | 103.76B |